From Vial to Vein: Crucial Gaps in Mesenchymal Stromal Cell Clinical Trial Reporting
Retrospective analysis of clinical trial outcomes is a vital exercise to facilitate efficient translation of cellular therapies.These analyses are particularly important for mesenchymal stem/stromal Intakes cell (MSC) products.The exquisite responsiveness of MSCs, which makes them attractive candidates for immunotherapies, is a double-edged sword;